MRSO Valuation Multiples

Discover MRSO's revenue and EBITDA valuation multiples and investment history, alongside public comparables like EBM Technologies, Resonance Health, Proteomics, Firefly Neuroscience and more.

MRSO Overview

About MRSO

MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.


Founded

2015

HQ

Japan

Employees

24

Website

mrso.co.jp

Financials (LTM)

Revenue: $7M
Net Income: ($150K)

EV

$9M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MRSO Financials

MRSO reported last 12-month revenue of $7M.

In the same LTM period, MRSO generated had net loss of ($150K).

Revenue (LTM)


MRSO P&L

In the most recent fiscal year, MRSO reported revenue of $7M and EBITDA of ($197K).

MRSO is unprofitable as of last fiscal year, with gross margin of 76%, EBITDA margin of (3%), and net margin of (2%).

See analyst estimates for MRSO
LTMLast FY202320242025202620272028
Revenue$7M$7M$11M$8M$7M
Gross Profit-$5M$9M$6M$5M
Gross Margin-76%80%77%76%
EBITDA-($197K)$4M$1M($197K)
EBITDA Margin-(3%)34%12%(3%)
EBIT Margin(3%)(3%)34%12%(3%)
Net Profit($150K)($144K)$2M$634K($144K)
Net Margin(2%)(2%)21%8%(2%)
Net Debt-($10M)---

Financial data powered by Morningstar, Inc.

MRSO Stock Performance

MRSO has current market cap of $19M, and enterprise value of $9M.

Market Cap Evolution


MRSO's stock price is $5.41.

MRSO share price decreased by 24.2% in the last year.

MRSO has an EPS (earnings per share) of $-0.04.

See more trading valuation data for MRSO
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9M$19M-4.5%-6.8%-24.2%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MRSO Valuation Multiples

MRSO trades at 1.2x EV/Revenue multiple, and (43.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for MRSO

EV / Revenue (LTM)


MRSO Financial Valuation Multiples

As of September 1, 2026, MRSO has market cap of $19M and EV of $9M.

MRSO has a P/E ratio of (126.4x).

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.3x0.7x1.0x1.3x
EV/EBITDA-(43.2x)2.2x8.3x(43.2x)
EV/EBIT(39.5x)(40.1x)2.2x8.6x(40.1x)
EV/Gross Profit-1.7x0.9x1.3x1.7x
P/E(126.4x)(131.9x)7.8x29.9x(131.9x)
EV/FCF-(52.6x)31.5x(17.5x)(52.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MRSO Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MRSO Margins & Growth Rates

In the most recent fiscal year, MRSO reported gross margin of 76%, EBITDA margin of (3%), and net margin of (2%).

See estimated margins and future growth rates for MRSO

MRSO Margins

Last FY20242025202720282029
Gross Margin76%77%76%
EBITDA Margin(3%)12%(3%)
EBIT Margin(3%)12%(3%)
Net Margin(2%)8%(2%)
FCF Margin(2%)(6%)(2%)

MRSO Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(26%)(19%)
Gross Profit Growth(29%)(20%)
EBITDA Growth(73%)(119%)
EBIT Growth(75%)(121%)
Net Profit Growth(74%)(123%)
FCF Growth(280%)(67%)

Data powered by FactSet, Inc. and Morningstar, Inc.

MRSO Operational KPIs

MRSO's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for MRSO
Last FY202320242025202620272028
Revenue per Employee$0.3M---
Opex per Employee$0.2M---
Opex to Revenue80%46%65%80%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
EBM Technologies2.0x-18.8x-
Resonance Health2.7x-(32.6x)-
Proteomics18.1x4.8x(1.8x)(2.6x)
Firefly Neuroscience7.3x-(0.4x)-
CareView Communications4.6x-488.0x-
MRT0.5x0.5x6.4x-
TempraMed Technologies9.2x-(1.0x)-
Metacare3.0x-18.1x-

This data is available for Pro users. Sign up to see all MRSO competitors and their valuation data.

Start Free Trial

MRSO VC Funding History

Before going public, MRSO raised $3M in total equity funding, across 1 round.


MRSO Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Apr-17Strategic investmentAflac Global Ventures$3M-MRSO is a medical consulting platform designed to connect doctors, hospitals, and patients. The company's platform provides medical specialists including doctors and nurses to explain medical knowledge and guide patients to appropriate departments and sites, enabling patients to consult about illnesses, hospital visits, treatments, and other medical issues at any time. MRSO raised a total of $2.6 million in funding over 2 rounds, with its latest funding round occurring on April 12, 2017, from Aflac Global Ventures and JAFCO. However, specific valuation, revenue, and financial metrics at the time of funding are not available in the sources.

Investments by MRSO

MRSO has invested in 1 company to date.

Latest investment by MRSO was on August 20th 2026. MRSO invested in AI Dock in their $2M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by MRSO

AI Dock
Description
AI Dock is a healthcare technology company that builds an AI-driven platform for early detection via full-body imaging scans.
HQ CountryJapan
HQ City
Tokyo
Deal Date20 Aug 2026
RoundSeed
Raised$2M
InvestorsBio Engineering Capital; Kunihiro Tanaka; MRSO
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all MRSO investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MRSO

When was MRSO founded?MRSO was founded in 2015.
Where is MRSO headquartered?MRSO is headquartered in Japan.
How many employees does MRSO have?As of today, MRSO has over 24 employees.
Is MRSO publicly listed?Yes, MRSO is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of MRSO?MRSO trades under 5619 ticker.
When did MRSO go public?MRSO went public in 2023.
Who are competitors of MRSO?MRSO main competitors include EBM Technologies, Resonance Health, Proteomics, Firefly Neuroscience, CareView Communications, MRT, TempraMed Technologies, Metacare, Cambridge Cognition, Beamtree.
What is the current market cap of MRSO?MRSO's current market cap is $19M.
What is the current revenue of MRSO?MRSO's last 12 months revenue is $7M.
What is the current EV/Revenue multiple of MRSO?Current revenue multiple of MRSO is 1.2x.
Is MRSO profitable?No, MRSO is not profitable.
What is the current net income of MRSO?MRSO's last 12 months net income is ($150K).
How many companies MRSO has acquired to date?MRSO hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies MRSO has invested to date?As of September 2026, MRSO has invested in 1 company.
What was the last MRSO investment?On 20th August 2026 MRSO invested in AI Dock, participating in a $2M Seed round, alongside Bio Engineering Capital and Kunihiro Tanaka.
In what companies MRSO invested in?MRSO invested in AI Dock.

See public comps similar to MRSO

Lists including MRSO

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial